China wants to act as a mediator in Ukraine but continues to stand closely alongside Russia. In an interview with Michael Radunski, Chinese scholar Wang Zichen explains the reasons for China's stance and what the West could do to get China on its side. One possibility: resuming negotiations on the CAI investment agreement.
By Redaktion Table
The US pharmaceutical company Pfizer has renegotiated a contract from 2021 with the EU Commission. According to media reports, several hundred million euros in cancellation fees are at stake for Germany alone. The European Parliament wants to clarify the background. But instead of answers, Pfizer sends a catalog of questions.
By Eric Bonse